Beta Amyloid Antibody
Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonal immunoglobulin G1 (IgG1) antibody specifically targeting the serum amyloid P component (SAP), a protein universally found in all types of amyloid deposits, and it possesses potential anti-amyloid activity by triggering an immunotherapeutic mechanism for the clearance of amyloid fibrils through macrophage-mediated phagocytosis, which can be applied in the research of amyloid light-chain (AL) amyloidosis and other systemic amyloid diseases.
Product Specifications
Product Name Alternative
Anti-Serum Amyloid P/SAP Reference Antibody (Dezamizumab), GSK2398852, GSK 2398852
Target
Beta Amyloid
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Neuroscience
Concentration
5.28 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.82 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GFAP (ASTRO/789), CF647 conjugate, 0.1mg/mL
